Eli Lilly Revenue 2006-2020 | LLY

Eli Lilly annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Eli Lilly revenue for the quarter ending June 30, 2020 was $5.499B, a 2.44% decline year-over-year.
  • Eli Lilly revenue for the twelve months ending June 30, 2020 was $22.950B, a 5.89% increase year-over-year.
  • Eli Lilly annual revenue for 2019 was $22.32B, a 3.84% increase from 2018.
  • Eli Lilly annual revenue for 2018 was $21.493B, a 7.61% increase from 2017.
  • Eli Lilly annual revenue for 2017 was $19.974B, a 5.88% decline from 2016.
Eli Lilly Annual Revenue
(Millions of US $)
2019 $22,320
2018 $21,493
2017 $19,974
2016 $21,222
2015 $19,959
2014 $19,616
2013 $23,113
2012 $22,603
2011 $24,287
2010 $23,076
2009 $21,836
2008 $20,372
2007 $18,634
2006 $15,691
2005 $14,645
Eli Lilly Quarterly Revenue
(Millions of US $)
2020-06-30 $5,499
2020-03-31 $5,860
2019-12-31 $6,114
2019-09-30 $5,477
2019-06-30 $5,637
2019-03-31 $5,092
2018-12-31 $5,638
2018-09-30 $5,307
2018-06-30 $5,585
2018-03-31 $4,964
2017-12-31 $3,263
2017-09-30 $5,658
2017-06-30 $5,824
2017-03-31 $5,228
2016-12-31 $5,761
2016-09-30 $5,192
2016-06-30 $5,405
2016-03-31 $4,865
2015-12-31 $5,376
2015-09-30 $4,960
2015-06-30 $4,979
2015-03-31 $4,645
2014-12-31 $5,121
2014-09-30 $4,876
2014-06-30 $4,936
2014-03-31 $4,683
2013-12-31 $5,809
2013-09-30 $5,773
2013-06-30 $5,930
2013-03-31 $5,602
2012-12-31 $5,957
2012-09-30 $5,443
2012-06-30 $5,601
2012-03-31 $5,602
2011-12-31 $6,047
2011-09-30 $6,148
2011-06-30 $6,253
2011-03-31 $5,839
2010-12-31 $6,187
2010-09-30 $5,655
2010-06-30 $5,749
2010-03-31 $5,486
2009-12-31 $5,934
2009-09-30 $5,562
2009-06-30 $5,293
2009-03-31 $5,047
2008-12-31 $5,204
2008-09-30 $5,210
2008-06-30 $5,150
2008-03-31 $4,808
2007-12-31 $5,190
2007-09-30 $4,587
2007-06-30 $4,631
2007-03-31 $4,226
2006-12-31 $4,245
2006-09-30 $3,864
2006-06-30 $3,867
2006-03-31 $3,715
2005-12-31 $3,879
2005-09-30 $3,601
2005-06-30 $3,668
2005-03-31 $3,497
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $147.459B $22.320B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.765B 18.72
Roche Holding AG (RHHBY) Switzerland $320.783B 0.00
Merck (MRK) United States $217.034B 15.49
Novartis AG (NVS) Switzerland $208.134B 16.18
Pfizer (PFE) United States $203.549B 12.72
Novo Nordisk (NVO) Denmark $163.517B 26.61
AbbVie (ABBV) United States $159.029B 9.69
AstraZeneca (AZN) United Kingdom $148.146B 28.80
Sanofi (SNY) $131.317B 15.61
GlaxoSmithKline (GSK) United Kingdom $98.485B 12.91
Bayer (BAYRY) Germany $63.190B 9.11
H Lundbeck (HLUYY) Denmark $6.681B 11.61
Innoviva (INVA) United States $1.173B 5.61